Theraclion wins AMA approval for new Category III CPT code for Sonovein varicose vein treatment

  • Theraclion won AMA CPT Editorial Panel clearance for a new Category III CPT code covering Sonovein HIFU treatment of varicose veins.
  • The code takes effect Jan. 1, 2027, supporting payer engagement ahead of a planned US launch by year-end 2026.
  • Sonovein’s De Novo FDA application was filed in December 2025; a decision is expected in late Q3 or early Q4 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theraclion SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260608251709) on June 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.